Answers are grounded in this paper and cite their sources.
INTRODUCTION/OBJECTIVE: Women with systemic lupus erythematosus (SLE) exhibit increased cardiovascular risk, partly explained by adverse fat distribution. This multicenter cross-sectional study investigated whether fat-free mass (FFM) is independently related to lipid metabolism and cardiovascular risk and identified metabolic clusters combining body composition and lipid parameters in women with SLE from an Ibero-American cohort. METHODS AND PROCEDURES: In this cross-sectional study, clinical, biochemical, anthropometric, and body composition data from 285 adult women with SLE from Brazil, Mexico, and Spain were analyzed. Multivariable linear regression models examined associations between FFM (%) and lipid parameters and cardiovascular risk indices. Model 1 was adjusted for age and center; Model 2 additionally for disease activity and duration; and Model 3 further for hydroxychloroquine dose. RESULTS: Higher FFM was independently associated with a more favorable lipid profile. In the fully adjusted model, FFM was inversely associated with LDL-C (p = 0.032), Castelli I (p = 0.032), Castelli II (p = 0.026), and LAP (p < 0.001), and positively associated with HDL-C (p = 0.048). Associations with triglycerides observed in partially adjusted models were attenuated after full adjustment. CONCLUSIONS: In women with SLE, greater fat-free mass was associated with a more favorable lipid profile and selected atherogenic indices, independent of demographic and disease-related factors. Although causality cannot be inferred due to the cross-sectional design, these findings suggest that lean mass may represent an important component of cardiometabolic health in SLE.
No takes yet. Share an insight, caveat, or question.
Mota et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: